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Mitochondria are the organelles responsible for producing the majority of a cell’s ATP and also play an essential role
in gamete maturation and embryo development. ATP production within the mitochondria is dependent on proteins
encoded by both the nuclear and the mitochondrial genomes, therefore co-ordination between the two genomes is
vital for cell survival. To assist with this co-ordination, cells normally contain only one type of mitochondrial DNA
(mtDNA) termed homoplasmy. Occasionally, however, two or more types of mtDNA are present termed hetero-
plasmy. This can result from a combination of mutant and wild-type mtDNA molecules or from a combination of
wild-type mtDNA variants. As heteroplasmy can result in mitochondrial disease, various mechanisms exist in the nat-
ural fertilization process to ensure the maternal-only transmission of mtDNA and the maintenance of homoplasmy in
future generations. However, there is now an increasing use of invasive oocyte reconstruction protocols, which tend
to bypass mechanisms for the maintenance of homoplasmy, potentially resulting in the transmission of either form of
mtDNA heteroplasmy. Indeed, heteroplasmy caused by combinations of wild-type variants has been reported follow-
ing cytoplasmic transfer (CT) in the human and following nuclear transfer (NT) in various animal species. Other
techniques, such as germinal vesicle transfer and pronuclei transfer, have been proposed as methods of preventing
transmission of mitochondrial diseases to future generations. However, resulting embryos and offspring may contain
mtDNA heteroplasmy, which itself could result in mitochondrial disease. It is therefore essential that uniparental
transmission of mtDNA is ensured before these techniques are used therapeutically.
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Introduction
Mitochondria are found in all eukaryotic cells and are essential to
cellular function because of their ability to generate ATP, the
cell’s major source of energy. They comprise a double membrane
with the outer membrane separating the mitochondrial matrix
from the cytoplasm of the cell, whereas the inner membrane forms
the cristae. Mitochondrial cristae are the site of the electron trans-
fer chain (ETC), the final stage in cellular respiration where oxida-
tive phosphorylation (OX-PHOS) takes place (Sherratt, 1991).
This aerobic process allows further metabolism of the products of
anaerobic glycolysis and the citric acid cycle to produce carbon
dioxide and water, with the subsequent release of 32 molecules of
ATP. This is a far more economical return than provided by anaer-
obic generation of ATP (Pfeiffer et al., 2001). The ETC consists
of five enzyme complexes, each containing multiple polypeptide
subunits (Figure 1). Electrons flow through the first four com-
plexes of the ETC releasing protons from the mitochondria which
set up the mitochondrial membrane potential. Pumping these pro-
tons back into the mitochondria through the fifth complex results
in the generation of ATP.
The importance of ATP in oocytes and early embryos has been
demonstrated in cattle, as assessed by morphology. Here, the
higher quality oocytes contained significantly higher levels of
ATP than poorer quality oocytes (Stojkovic et al., 2001). Those
containing the highest ATP levels also progressed to produce a
significantly higher proportion of blastocysts. A similar pattern
has been demonstrated in human oocytes, with those containing at
least 2ρmol ATP at fertilization being more capable of embryonic
development and implantation (Van Blerkom et al., 1995). The
correlation between mitochondrial distribution in individual blast-
omeres and blastomere ATP content further emphasizes the
importance of OX-PHOS for early preimplantation development
(Van Blerkom et al., 2000).
Mitochondrial DNA
Components of the ETC are encoded by both chromosomal and
mitochondrial DNA (mtDNA), with all components being
required for efficient function of the ETC. The human mitochon-
drial genome is a double-stranded circular DNA consisting of
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16 569 base pairs (Anderson et al., 1981). Using a slightly different
genetic code to that of nuclear DNA, mtDNA encodes 13 polypep-
tides involved in the ETC, 22 transfer (t)RNAs and 2 ribosomal
(r)RNAs (Anderson et al., 1981). MtDNA codes for seven subunits
of nicotinamide adenine dinucleotide (NADH) dehydrogenase (ND;
complex I), one component of complex III, three subunits of cyto-
chrome C oxidase (complex IV) and two subunits of ATP synthase
(complex V). All other components of the ETC are encoded by the
nuclear genome (Figure 1). The mitochondrial genome is highly
compact, with no introns contained between the coding regions
(Anderson et al., 1981) and some of the coding regions even overlap
(ATPase 6 and ATPase 8, ND4 and ND4L; Anderson et al., 1981).
Others lack termination codons, with these sequences being pro-
vided by post-transcriptional polyadenylation (Ojala et al., 1981).
Despite its small size in comparison with the nuclear genome, the
host cell depends on the mitochondrial genome for aerobic respira-
tion as much as the mitochondria rely on proteins encoded by the
host cell’s nuclear DNA. In fact, as much as one third of the total
DNA content of an oocyte consists of mtDNA (Piko and Mat-
sumoto, 1976). Somatic cells have between 103 and 104 copies of
mtDNA, with 2–10 copies per organelle (Satoh and Kuroiwa,
1991), correlating to each particular cell’s requirement for OX-
PHOS. For example, it has been reported that human subcutaneous
fat cells contain more mtDNA copies than peripheral blood mono-
nuclear cells (Gahan et al., 2001) and that liver tissue contains more
mtDNA than various muscle tissues (Wiesner et al., 1992).
MtDNA transcription and replication
Transcription of mtDNA occurs following interaction between
nuclear-encoded regulatory proteins and regions within the D-loop
of mtDNA (Figure 2). Requirements for transcription include the
mitochondrial RNA polymerase (Tiranti et al., 1997), mitochon-
drial transcription factor A (TFAM; Fisher and Clayton, 1985;
1988), and one of the recently identified TFB1M and TFB2M
(Falkenberg et al., 2002; Table I). Once initiated, transcription
generates a polycistronic precursor RNA transcript, allowing co-
ordinated transcription of all genes on the same strand. Excision of
the polycistronic precursor by endonucleases produces precursor
rRNAs and tRNAs, which are then processed further to allow
them to translate the precursor mRNAs (Ojala et al., 1981).
The replication of mtDNA is also dependent on nuclear-
encoded regulatory proteins (Table I). The replication process
begins with light strand transcription from the light strand pro-
moter region to the second conserved sequence block (CSB)
within the D-loop region, producing an RNA sequence comple-
mentary to the light strand DNA (Xu and Clayton, 1995). Binding
of the mtDNA-specific polymerase gamma (PolG) to the resulting
RNA–DNA hybrid allows replication of the heavy strand to begin
from the origin of heavy strand replication (OH) contained within
the D-Loop (Figure 2). After the replication of approximately two
thirds of the genome, the formation of the new heavy strand
exposes the origin of light strand replication (OL) on the heavy
strand parent. Light strand replication is then able to commence in
the opposite direction.
As mtDNA transcription and replication, and therefore cellular
ATP-generating capacity, are so dependent on proteins encoded
by the nuclear genome, mutations in these genes can result in
mtDNA depletion syndromes (reviewed by Suomalainen and
Kaukonen, 2001). Unlike the vast majority of mtDNA diseases,
these diseases can be transmitted in a Mendelian fashion and
include chronic progressive external ophthalmoplegia (CPEO;
Van Goethem et al., 2001; Graziewicz et al., 2004) and Alpers
syndrome (Naviaux et al., 1999). This effect is also mimicked by
Figure 1. The electron transfer chain (ETC) is the final stage in cellular respiration where oxidative phosphorylation (OX-PHOS) takes place. The ETC consists of
five enzyme complexes which, with the exception of complex II, all consist of polypeptides encoded by both the nuclear and the mitochondrial genomes. Electrons
flow through the first four complexes of the ETC releasing protons (H+) from the mitochondria and thereby setting up the mitochondrial membrane potential.
Pumping these protons back into the mitochondria through the fifth complex results in ATP generation. CoQ, Coenzyme Q; Cyt C, Cytochrome C; ANT, adenosine
nucleoside transporter; KCN, potassium cyanide; ADP, adenosine diphosphate; ATP, adenosine triphosphate.
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nucleoside antiretroviral analogues such as 3′-azido-3′-deoxythy-
midine (AZT) and 2′3′-dideoxycytidine (ddC). For example, men
treated with these drugs for 12 months had increased numbers of
deleted mtDNA molecules in their sperm samples (White et al.,
2001). Furthermore, although heterozygous PolG knockout mice
develop normally, despite slightly reduced mtDNA levels,
homozygous knockouts have severe mtDNA depletion and do not
survive beyond embryonic day 8.5 (Hance et al., 2005).
TFAM plays an important role in both transcription and replica-
tion of the mitochondrial genome. It is therefore not surprising
that low levels of TFAM have been associated with a variety of
mitochondrial depletion syndromes, such as infantile mitochon-
drial myopathy (Poulton et al., 1994), familial mtDNA-associated
liver disease (Spelbrink et al., 1998), fatal childhood myopathy
(Larsson et al., 1994), skeletal muscle and mitochondrial encepha-
lomyopathy disorders (Siciliano et al., 2000) and ocular myopa-
thy, exercise intolerance and muscle wasting (Tessa et al., 2000).
In contrast, there is a decrease in TFAM expression localized to
the mitochondria during spermatogenesis. This has been proposed
as a functional mechanism for specifically reducing mtDNA copy
number in maturing sperm and therefore paternal mtDNA trans-
mission to future generations, in both the human (Larsson et al.,
1997) and the mouse (Larsson et al., 1996). This arises at the late
spermatocyte/early spermatid stage where an isoform is expressed
lacking the mitochondrial targeting sequence. In the mouse,
TFAM was also detected in the nucleus of developing sperm cells,
indicating a possible further role as a nuclear transcription factor
(Larsson et al., 1996). The significance of TFAM expression as a
major regulator of mtDNA copy number is exemplified in
homozygous knockout mouse embryos that are completely
depleted of mtDNA and do not survive after embryonic day 10.5
(Larsson et al., 1998).
The replication of embryonic mtDNA, at least in the mouse,
does not occur during early preimplantation development (Piko
Figure 2. Mitochondrial DNA (mtDNA) transcription and replication origins in the D-loop. Mitochondrial transcription factor A (TFAM) binds and separates the
two DNA strands. The accessory transcription factor, either TFB1M or TFB2M, allows mitochondrial RNA polymerase (mtRNAPol) to bind to the correct part of
the DNA to produce the transcripts and the RNA primer for replication. Mitochondrial DNA polymerase gamma (PolG) is then able to use the primer to produce the
daughter DNA strand. HSP, heavy strand promoter; LSP, light strand promoter; CSB, conserved sequence block; OH, origin of heavy strand replication; D-loop, dis-
placement loop, the non-coding region that is the binding site for nuclear-encoded transcription and replication factors; Phe tRNA, phenylalanine transfer RNA; Pro
tRNA, proline transfer RNA.
Table I. Major nuclear-encoded regulatory factors required for mitochondrial 
DNA (mtDNA) transcription and replication
MTERF, mitochondrial transcription termination factor; mtRNAPol,
mitochondrial RNA polymerase; mtSSB, mitochondrial single-stranded
binding protein; PolG, polymerase gamma; RNase MRP, mitochondrial RNA
processing endoribonuclease; TFAM, mitochondrial transcription factor A;
TFB1M/TFB2M, mitochondrial transcription factor B1 or B2.
Protein Binding site Role
TFAM Enhancer region Causes unwinding of mtDNA, 
exposing the binding site for 
mtRNA polymerase
TFB1M or 
TFB2M
RNA polymerase Form heterodimer with RNA 
polymerase allowing specific 
transcription initiation
MtRNAPol Transcription 
initiation region
Produces RNA copy of 
mtDNA sequence
PolG RNA–DNA hybrid Produces replicate copy 
of mtDNA
MtSSB Single-stranded mtDNA Prevents re-annealing of 
single-stranded mtDNA 
allowing PolG polymerization
MTERF RNA polymerase Termination of transcription
RNase MRP MtDNA primary light 
strand transcript
Processing of primary light 
strand transcripts to produce 
RNA primer for replication
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and Taylor, 1987). However, a small window of replication at the
two-cell stage was recently reported (McConnell and Petrie, 2004).
The mtDNA molecules present in the mature oocyte at fertilization
are therefore largely relied upon to provide sufficient ETC compo-
nents to allow OX-PHOS activity during the preimplantation phase
of embryonic development. In order to meet this demand, mtDNA
is amplified during oocyte maturation within the ovary, with a
45-fold increase being reported in cattle from the primordial
germ cells stage to pre-ovulating oocytes (Smith and Alcivar,
1993), resulting in a mean of 260 000 copies being present in
mature bovine oocytes (Michaels et al., 1982). Similar amplifi-
cations have been reported in other species. For example, human
premigratory primordial germ cells possess approximately 10
mitochondria per cell (Jansen and De Boer, 1998). Mature
mouse oocytes contain mean mtDNA copy number values
between 119 000 (Piko and Taylor, 1987) and 159 000 (Steuerwald
et al., 2000). In the human, copy number ranges from 10 000 to
700 000 (Almeida-Santos et al., 2006), with other reported mean
values of 314 000 (Steuerwald et al., 2000) and 193 000
(Reynier et al., 2001).
Oocytes with higher copy numbers of mtDNA are known to be
associated with improved fertilization rates. For example, human
oocytes failing to fertilize because of poor sperm quality, and
therefore assumed to be of good quality, had significantly higher
mtDNA copy number than poor quality oocytes which were ferti-
lized by good quality sperm (mean 255 000 versus 152 000 copies;
Reynier et al., 2001). Furthermore, low-quality oocytes from
patients with a variety of ovarian disorders contained an average
of 100 000 mtDNA molecules compared with an average of 256 000
copies in oocytes from healthy individuals (May-Panloup et al.,
2005). We have also recently reported similar results in porcine
(El Shourbagy et al., 2006) and human (Almeida-Santos et al.,
2006) oocytes. However, we also saw significantly different copy
number between arrested two-cell human embryos and those that
developed further (Almeida-Santos et al., 2006). A putative
threshold number of mtDNA molecules has been proposed for the
mature unfertilized oocyte to allow embryo development to take
place after fertilization. In the mouse, this has been predicted at
approximately 100 000 copies per oocyte (Piko and Taylor, 1987), with
a similar value being appropriate for the pig (El Shourbagy et al., 2006).
The relevance of mtDNA copy number threshold to 
fertilization outcome and embryo development
The number of mtDNA copies per organelle is indicative of the
number of mitochondria in an oocyte. In the mouse, each mito-
chondrion has just one copy (Piko and Taylor, 1987). Conse-
quently, the minimum number of mtDNA copies would indicate
the minimum number of mitochondria required for fertilization to
take place. These mitochondria would support embryonic devel-
opment to cavitation, after which glycolysis becomes increasingly
important in many species (human – Leese et al., 1993; pig –
Sturmey and Leese, 2003; cow – Thompson et al., 1996; rat – Brison
and Leese, 1991; mouse – Houghton et al., 1996). Furthermore,
this minimum number may be essential as it has been hypothe-
sized that a threshold level of ATP is required to energize cell
division (Brenner et al., 2000) and may also synchronize mito-
chondrial dynamics. The distribution of mitochondrial networks
throughout the cell varies with different stages of the cell cycle
(Margineantu et al., 2002). Mature and immature oocytes also
have distinct patterns of mitochondrial distribution (Stojkovic et
al., 2001; Nishi et al., 2003). Those oocytes with mtDNA copy
number lower than the required threshold may be unable to form
the networks required for developmental competence. In support
of this, developmental competence appears to be related to the
numbers of mitochondria present (El Shourbagy et al., 2006).
In sea urchin oocytes, mitochondria act as calcium sinks (Eisen
and Reynolds, 1985). The Ca2+ wave pacemaker that is necessary
for the completion of meiosis at fertilization is maintained by mito-
chondrial uptake of Ca2+ (Dumollard et al., 2003). Failure to main-
tain the Ca2+ wave pacemaker results in apoptotic cell death of the
oocyte (Liu et al., 2001). Therefore, oocytes with low levels of ATP
production, because of low levels of mitochondria and mtDNA,
may be unable to maintain the Ca2+ wave pacemaker and complete
meiosis, and instead, undergo apoptosis. We have previously
hypothesized that oocytes without sufficient wild-type mtDNA, and
therefore the capacity to generate ATP would not normally be ovu-
lated (St. John, 2002). This is reflected in the low numbers of
mtDNA observed in degenerate oocytes (mean = 44 629 ± 40 729;
Almeida-Santos et al., 2006). Consequently, the use of superovula-
tion protocols during IVF allows these low-quality oocytes to
undergo the maturation process and the inadequacies of insufficient
mtDNA molecules to be observed (St. John, 2002).
Mitochondrial morphology changes after oocyte maturation to
the inactive state (Bavister and Squirrell, 2000). This may be
because of the lack of mtDNA replication and the import of nuc-
lear-encoded regulatory factors from the cytoplasm. However OX-
PHOS is still functional during early embryo development, and
mitochondria are dynamic organelles, moving to provide ATP
where it is most needed (Stojkovic et al., 2001). Staining of mito-
chondria has shown that during embryo development, they cluster
around the nucleus of blastomeres during the cleavage stages,
providing the energy required for cell division processes such as
spindle formation. However, when cell division is not taking
place, they tend to spread throughout the cytoplasm of the cell
(Stojkovic et al., 2001; Sun et al., 2001; Wilding et al., 2001).
Equal segregation of mitochondria following cell division
reduces the possibility of resulting tissues of the offspring lacking
the ability to produce sufficient ATP through OX-PHOS. How-
ever, disproportionate numbers of mitochondria among blast-
omeres has been reported in the pig (El Shourbagy et al., 2006)
and human (Van Blerkom et al., 2000; Lin et al., 2004). This may
result in some blastomeres with reduced ATP-generating capacity.
If this occurs early on in development, blastomeres may fragment,
resulting in embryo arrest or less competent blastocysts with fewer
cell numbers. In the human, mitochondrial morphology changes
back to the active state at the eight-cell stage, coinciding with the
activation of the embryonic genome (Sathananthan and Trounson,
2000). Furthermore, during cavitation, shortly after embryonic
genome activation, there is an increased dependence on glycolysis
in most mammalian species (see Van Blerkom et al., 2002 for dis-
cussion). This would suggest that nuclear embryonic genome acti-
vation provides a signal to the mitochondria to reduce OX-PHOS
activity. Increased use of glycolysis may allow embryonic cells that
are no longer able to generate sufficient ATP through OX-PHOS
to survive for long enough to enable production and import of nuc-
lear-encoded regulatory factors necessary for the onset of mtDNA
replication post-implantation (El Shourbagy et al., 2006). Indeed,
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studies in pigs using OX-PHOS inhibitors have indicated that the
inhibition of OX-PHOS function at compaction can improve
embryo viability (Machaty et al., 2001). This hypothesis is sup-
ported by reports of glycolysis rather than OX-PHOS metabolism
occurring in other cell types with a functioning nuclear genome
but low mtDNA copy number, including somatic cells being
depleted of their mtDNA (King and Attardi, 1989). However, ATP
production through glycolysis is far less efficient than through
OX-PHOS. It is therefore vital that sufficient mtDNA molecules
are present at fertilization to maintain embryo survival until
mtDNA replication resumes.
The relevance of mtDNA replication to maternal 
transmission of mtDNA
MtDNA is further unlike nuclear DNA as it does not follow the
normal Mendelian pattern of inheritance but is maternally inher-
ited (Giles et al., 1980). Owing to its size, a mature oocyte can
contain far more mitochondria in its cytoplasm than the fertilizing
sperm cell. Coupled with replication of the mitochondrial genome
during oocyte maturation in the ovary, this results in an oocyte :
sperm mtDNA ratio of 1000:1 (Ankel-Simons and Cummins,
1996), with sperm mtDNA contributing approximately only 100
molecules at fertilization (Hecht and Liem, 1984).
MtDNA is usually homoplasmically transmitted, i.e. only one
mtDNA genotype being present (Monnat et al., 1985). Occasion-
ally, two or more mtDNA genotypes can be present, often because
of either a pathological or a non-pathological rearrangement,
resulting in heteroplasmy, as in the oocytes of women harbouring
a mtDNA disease (Blok et al., 1997). MtDNA has a much higher
mutation rate than nuclear DNA (Wallace et al., 1987). This is a
consequence of the production of mutagenic free radicals within
the mitochondria, which are further confounded by limited
mtDNA repair mechanisms (Yakes and Van Houten, 1997).
Furthermore, mtDNA is not stabilized with histones as is the case
for nuclear DNA, although TFAM is now thought to be involved
in mtDNA packaging (Alam et al., 2003). Despite the high muta-
tion rate, mtDNA has been highly conserved throughout evolu-
tion, and when it arises, mtDNA heteroplasmy tends to revert back
to homoplasmy sometimes within one generation (Koehler et al.,
1991).
MtDNA replication does not occur in synchrony with nuclear
DNA replication, and therefore some mtDNA genomes are not
replicated during one-cell cycle, whereas others are copied many
times (Sazer and Sherwood, 1990). It has been reported that there
is a preferential replication of those mtDNA molecules that are
closer to the nucleus (Davis and Clayton, 1996), perhaps because
of the faster diffusion of nuclear-encoded regulatory factors. The
introduction of exogenous mtDNA into zygotes either close to the
nucleus or at the periphery influences the amount of exogenous
mtDNA observed at the blastocyst stage, with higher proportions
arising from karyoplast injections (Meirelles and Smith, 1998).
Consequently, the position of mitochondria in the early embryo
may play a role in determining which mtDNA genomes are
selected for amplification.
Contradictory data have recently shown that mtDNA replication
is not just restricted to mitochondria in proximity to the nucleus
(Magnusson et al., 2003). Here, it was demonstrated that all com-
ponents of the replication machinery were available in sufficient
quantities throughout the cell, allowing replication to take place
throughout the entire cytoplasm. This included PolG and TFAM.
The previously reported preferential labelling of mtDNA near cell
nuclei was suggested to be because of denser aggregation of mito-
chondria around nuclei (Magnusson et al., 2003). MtDNA replica-
tion throughout the cell cytoplasm is supported by a lack of
evidence for selection against pathogenic mtDNA mutations in
oogenesis or early embryonic development (reviewed by Shoubridge,
2000).
When mtDNA replication resumes following implantation
(Piko and Taylor, 1987), each cell type of the developing embryo
contains a few copies of mtDNA, as indicated by the few mito-
chondria present in undifferentiated embryonic stem cells (ESCs;
Sathananthan et al., 2002; St. John et al., 2005a). Consequently,
the combination of segregation followed by the amplification of
selected templates produces an mtDNA purification process
(Hauswirth and Laipis, 1982), which is important for the mainten-
ance of mtDNA homoplasmy. If blastomeres inherit mutated
genomes or are depleted of mitochondrial genomes, then the
resulting adult tissues would be deficient in OX-PHOS capacity,
which could result in the onset of mitochondrial disease (Wallace,
1992).
There are many diseases caused by mutations in mtDNA and
symptoms of these diseases generally appear in tissues highly
dependent on OX-PHOS (Wallace, 1992). These include Leber’s
hereditary optic neuropathy (LHON), which can result from muta-
tions in the gene for the NADH-Q oxidoreductase component of
complexes I and III (Brown et al., 1992). Myoclonic epilepsy with
ragged-red fibres (MERRF) is also transmitted by maternal inher-
itance and results in myoclonus, epilepsy and ataxia. This can res-
ult from mutations in mitochondrially encoded tRNA genes
(Hanna et al., 1995; Nakamura et al., 1995; Nishigaki et al., 2003;
Mancuso et al., 2004) and protein genes (Naini et al., 2005). As
well as point mutations, some mitochondrial diseases are caused
by large-scale deletions to the genome. The most well known in
this group is Kearns–Sayre Syndrome (KSS), which includes
symptoms of PEO, pigment retinopathy and disorders of cardiac
conduction (Klopstock et al., 1995; Lertrit et al., 1999; De Block
et al., 2004). The clinical phenotypes resulting from mtDNA
mutations are dependent on the proportion of mutated mtDNAs
(Wallace, 1992). In the case of LHON, >60% mutant mtDNA load
is required before the disease phenotype presents (Chinnery et al.,
2001). In some mitochondrial diseases, including a case of
MERRF, over 85% mutant mtDNAs need to be present before
symptoms are observed (Boulet et al., 1992).
Paternal mtDNA inheritance
There is increasing evidence demonstrating that maternal-only
mtDNA transmission is not merely because of dilution of the
paternal mitochondria beyond the level of detection. It has been
suggested that paternal mtDNA is actively eliminated by ubiquiti-
nation in the oocyte cytoplasm and subsequent proteolysis during
embryonic development (Sutovsky et al., 1999; Nishimura et al.,
2006). The elimination hypothesis is supported by reports demon-
strating reduced paternal mtDNA content as embryonic develop-
ment progresses (Cummins et al., 1997). Paternal mtDNA was
detected only as far as the pronucleus stage following intra-
specific mouse crosses compared with detection in neonates
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following inter-specific mouse crosses (Kaneda et al., 1995). This
suggests that the elimination mechanism is species specific. How-
ever, the elimination mechanism is not only species specific but
also tissue specific, as donor sperm mtDNA was eliminated,
whereas exogenous liver mtDNA injected into the oocyte per-
sisted at least until the neonatal period (Shitara et al., 2000).
The destruction of paternal mtDNA (reviewed in Sutovsky,
2003) and the presence of the genetic bottleneck should usually
result in homoplasmic individuals. Recently, the accepted theory
of uniparental mtDNA inheritance has been questioned. This is
especially so in the case of a male patient presenting with a mito-
chondrial myopathy who was found to have inherited his muscle
mtDNA from his father. However, the 2bp deletion giving rise to
his myopathy was de novo (Schwartz and Vissing, 2002). This
outcome is further supported by the evidence of sperm mtDNA
persistence in human polyploid IVF-generated blastocysts
(St. John et al., 2000). Paternal leakage of mtDNA has also been
reported following inter-specific crosses in fruitflies (Kondo et al.,
1990), mice (Gyllensten et al., 1991), honeybees (Meusel and
Moritz, 1993), birds (Kvist et al., 2003), sheep (Zhao et al., 2004)
and non-human primates (St. John and Schatten, 2004) and fol-
lowing intra-specific crosses in mussels (Zouros et al., 1992) and
fruitflies (Kondo et al., 1992). The ubiquitin-related paternal
mtDNA destruction process has therefore proven ineffective in
these cases. It is as yet unknown how paternal mtDNA might
escape the destruction process and how the paternal mtDNA might
be preferentially replicated in a particular tissue to such an extent
that it resulted in a mitochondrial disease (Schwartz and Vissing,
2002). In this latter instance, a considerable selective advantage
must have taken place to out-compete the maternal source of
mtDNA in the affected tissue.
A possible mechanism for bypassing the paternal mtDNA
destruction process is the fusion of parental mitochondria fol-
lowed by recombination of the two genomes. Recombination of
mammalian mtDNA was originally thought not to arise, although
it is known to occur in yeast. However, more recent evidence sug-
gests that it may also occur in mammals. For example, Ono and
colleagues created two respiration-deficient cell lines from
patients with mitochondrial diseases caused by different mutations
(Ono et al., 2001). Fusion of the two-cell lines resulted in mor-
phology and respiratory enzyme activity returning to normal
within 10–14 days. These authors proposed that the outcome
resulted from mtDNA recombination and genome compensation.
Mammalian mtDNA recombination has since been confirmed in
human cells using PCR-based techniques (D’Aurelio et al., 2004)
and recent sequence analysis of invertebrate and vertebrate spe-
cies, including primates (Tsaousis et al., 2005). These authors sug-
gested that recombination may have been previously missed
because of the purification process during oocyte production pro-
hibiting the generation of new haplotypes and their transmission to
the next generation. Recombination of sperm and oocyte mtDNA
is now thought to explain the presence of the 2bp deletion in the
male myopathy patient (Kraytsberg et al., 2004).
Invasive oocyte reconstruction protocols
The introduction of more advanced assisted reproductive technol-
ogies (ART) and their current use in the clinical setting and in animal
production further confounds the unimaternal transmission of
mtDNA. These technologies include (i) ICSI which is used clini-
cally; (ii) cytoplasmic transfer (CT) which has been used clinically
but is now, for example, banned in the United Kingdom and
United States and (iii) germinal vesicle transfer (GVT), pronuclear
transfer (PNT) and NT, which have not yet been used to treat
humans. These more invasive ART protocols present more oppor-
tunities for the violation of the normal pattern of mtDNA inherit-
ance. If uniparental mtDNA inheritance is not maintained
following these techniques, offspring may harbour various forms
of mtDNA heteroplasmy. Indeed, the introduction of these new
technologies results in heteroplasmy being redefined. In this
instance, either a wild-type molecule can co-exist with a rear-
ranged molecule or two wild-type molecules may persist in the
reconstructed oocyte.
ICSI
Unlike IVF, the ICSI procedure varies dramatically from the nat-
ural fertilization process. For example, the intact, non-capacitated,
non-acrosome-reacted sperm is injected into the oocyte. There are
also delays and alterations in post-fertilization processes following
ICSI, including male pronucleus formation (Luetjens et al., 1999)
and the calcium oscillations essential for the activation process
(reviewed in Ludwig et al., 2001). This delayed response after
sperm entry means that ICSI also has the potential to delay degra-
dation of sperm mtDNA. Furthermore, couples who have male
factor infertility and require ICSI are at a higher risk of using
sperm containing abnormal mtDNA as some human mtDNA hap-
logroups are associated with high or reduced sperm motility
(Ruiz-Pesini et al., 2000). This is demonstrated in those men har-
bouring large numbers of mtDNA deletions who are more likely to
exhibit poorer semen quality (Lestienne et al., 1997; Reynier
et al., 1997; St. John et al., 2001) as are those exhibiting point
mutations (Spiropoulos et al., 2002). Despite the many diversions
from the natural fertilization processes following ICSI, to date, it
appears that sperm mtDNA is eliminated in offspring generated
using this technique (Danan et al., 1999; Marchington et al.,
2002). Furthermore, it appears to be eliminated before the blasto-
cyst stage in ICSI-derived polyploid human embryos (St. John
et al., 2000).
CT
CT is an extension of ICSI and involves the injection of supple-
mentary cytoplasm, as well as a sperm, into the oocyte (Figure 3).
The rationale for using CT is that donor cytoplasm will contain
supplementary, often younger, non-mutated mtDNA and will pos-
sibly contain other important cytoplasmic components to compen-
sate for the defective cytoplasm in the oocyte (Cohen et al., 1997).
In the human, it has resulted in higher pregnancy rates and live
births (Cohen et al., 1997; Barritt et al., 2001). CT can also result
in heteroplasmy as demonstrated by the analysis of various tissues
of human CT offspring (Brenner et al., 2000). Consequently, it
remains to be demonstrated whether the donor mtDNA out-com-
petes the recipient mtDNA in the heteroplasmic offspring. We also
need to ascertain whether the coupling of two distinct genomes
accounted for the two cases of Turner’s syndrome, one electively
aborted and the other spontaneously aborted, and the one case of
pervasive development disorder (Barritt et al., 2001).
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To avoid the possible harmful effects of heteroplasmy in the
offspring, cytoplasm from granulosa cells of the mother rather
than cytoplasm from donor oocytes has been used (Kong et al.,
2003; 2004). These are likely to have the same mtDNA sequence
as the recipient oocyte. However, one possible problem with this
procedure is that mtDNA deletions in granulosa cells are more
common in older women (Seifer et al., 2002), i.e. those that are
likely to have defective oocytes and require CT. Therefore, the
treatment may be unsuccessful because of continued lack of wild-
type mtDNA and may even result in the transmission of mitochon-
drial disease to the offspring that would not have occurred without
CT. Another likely problem is that granulosa cells are fully differ-
entiated, whereas newly fertilized oocytes are pluripotent. Cells at
different stages of differentiation are known to be different in
terms of their mitochondrial activity and content. For example,
undifferentiated human (h) ESCs (Sathananthan et al., 2002; St. John
et al., 2005a) and primordial germ cells (Jansen and De Boer,
1998) have been observed to contain low numbers of mitochon-
dria. However, differentiated cells contain higher numbers of
more active mitochondria, depending on OX-PHOS requirements
of specific cell types (Moyes et al., 1998). Mitochondria donated
from granulosa cells would therefore need to be ‘reprogrammed’
to match those of the oocyte. We have supplemented developmen-
tally incompetent pig oocytes with pure populations of mitochon-
dria from developmentally competent oocytes from maternal
relatives. Interestingly, we observed improved fertilization outcome
and the maintenance of unimaternal inheritance (El Shourbagy
et al., 2006).
GVT and PNT
GVT and PNT have also been proposed as techniques to overcome
problems associated with aged oocytes, whereby the GV or PN is
transferred into an enucleated recipient oocyte. Ideally, the enucle-
ated recipient should be from the same stage of development as
the donor nucleus (Liu et al., 1999). In aged oocytes, there is
likely to be a larger number and higher proportion of mutant
mtDNA (Keefe et al., 1995). It has been hypothesized that mito-
chondria are important not only for the production of ATP but also
for correct chromosomal segregation during meiosis (Schon et al.,
Figure 3. Assisted reproductive techniques. Predicted outcomes associated with mitochondrial DNA (mtDNA) transmission following IVF, ICSI, cytoplasmic
transfer (CT), germinal vesicle transfer (GVT), pronuclei transfer (PNT) and somatic cell nuclear transfer (SCNT).
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2000). Furthermore, it has been suggested that aberrant mitochon-
drial function in aged oocytes may have a role in oocyte aneu-
ploidy (Eichenlaub-Ritter et al., 2004), a common cause of
infertility in older women (Munne et al., 1995; Dailey et al.,
1996). The chances of success may therefore increase if the nuc-
lear component of the aged oocyte was transferred into the enucle-
ated ooplasm of a younger, healthier oocyte, rather than
supplement the existing ooplasm. This transfer can be carried out
at either the GV or the PN stage (Figure 3). Indeed, studies using
human oocytes have shown GVT from aged oocytes to the enucle-
ated ooplasm of young oocytes can overcome oocyte aneuploidy,
with the majority of reconstructions having normal karyotypes
(Zhang et al., 1999; Takeuchi et al., 2001). There may also be
non-cytoplasmic components of the GV that influence chromo-
some segregation. This has been indicated in a series of mouse
experiments mixing GVs and ooplasms of varying ages (Cui et al.,
2005). A significantly greater number (57.1 %) of chromosomal
abnormalities were found in reconstructions when the GV was
transferred from older females to the enucleated ooplasm of
younger females. This is in contrast to abnormalities found in
reconstructions derived from the transfer of younger GVs into
aged ooplasms (16.7 %).
Mitochondria are known to be involved in chromosome organi-
zation and movement. For example, the induction of mitochon-
drial damage in mouse oocytes prevented oocyte maturation,
chromosomal segregation and spindle formation (Takeuchi et al.,
2005). This damage was overcome by GVT of the karyoplast
derived from a damaged oocyte into the ooplasm of a healthy enu-
cleated oocyte. Cytogenetic analysis showed that 20/21 of these
reconstructions had a normal number of chromosomes. Further-
more, performing ICSI on GVT reconstructions and transfer of the
resulting two-cell embryos led to the generation of live mouse off-
spring. It has also been demonstrated that an intact mouse ooplasm
could rescue mitochondrial-damaged karyoplasts induced by pho-
toirradiation with 62% of these reconstructions maturing to met-
aphase II (Palermo et al., 2002). PNT is essentially the same
procedure, except for the nuclear material being removed after fer-
tilization. This technique has also been used in mice with consid-
erable success as determined by the birth of live offspring
(Meirelles and Smith, 1997; 1998; He et al., 2003; Sato et al.,
2005). This procedure, however, involves the destruction of a
zygote, which may restrict its usage because of ethical and moral
considerations.
GVT and PNT have been proposed as techniques for treating
mtDNA disease (Cummins 1998; Trounson, 2001). However,
potential problems could arise as the transferred GV or PN is
still surrounded by mitochondria, which will also be carried over
into the donor ooplasm. These mitochondria remain close to the
centre of the immature reconstruction at first but then disperse
throughout the cytoplasm as maturation ensues (Fulka, 2004).
Owing to segregation during embryogenesis, this provides an
opportunity for karyoplast mitochondria to be present in all cell
types of the offspring. Any disease-associated mitochondria
transferred with the nuclear material may therefore continue to
be transmitted.
It is further possible that, due to its initial proximity to the
nucleus, karyoplast mtDNA would be preferentially replicated in
the reconstructions. Indeed, fusion of enucleated somatic cells with
mtDNA-depleted somatic cells can lead to the preferential expansion
of one particular type of mtDNA such as the mutant molecule
(Dunbar et al., 1995). Although, to our knowledge, there has been
no analysis of mtDNA transmission following GVT, results are
likely to be similar to those reported following PNT. In this
instance, exogenous mtDNA accompanying the murine zygotic
karyoplast is found in higher concentrations at blastocyst than
mtDNA from transferred cytoplasts (Meirelles and Smith, 1998).
This has been further highlighted where zygotic karyoplast trans-
fer into zygotes resulted in varying amounts of mtDNA being
transmitted to offspring (0–69%; Meirelles and Smith, 1997).
Consequently, it would be difficult to predict to what extent a
mutated or deleted mtDNA molecule would be selected. However,
a recent report suggests that the varying levels of mtDNA deletion
in mouse zygotes could be reduced to levels lower than those
expected for the phenotypic onset of mtDNA disease when the
zygotic nucleus is transferred into an enucleated healthy oocyte
(Sato et al., 2005). The subsequent offspring also remained under
the level for pathological onset even with the accumulative
increase of the deletion with time. These authors state however
that, in the human, this form of nuclear transplantation could not
be applied to those mtDNA diseases where the pathogenic muta-
tion had significant replicative advantage over wild-type mtDNA.
This is most likely as in humans the prenatal period is 13 times
longer than in the mouse, and this represents the window in which
mutant mtDNA replication is most proliferative (Sato et al.,
2005).
NT
NT involves the injection of a donor nucleus or a whole cell into
an enucleated recipient oocyte (Figure 3). Mostly commonly,
either embryonic cell (EC) NT, using a blastomere, or somatic cell
NT (SCNT) are performed. Resulting embryos have then been
used to generate blastocysts and offspring in a variety of species
(Campbell et al., 2005). However, NT is renowned for its low effi-
ciency, with low proportions of embryos developing to the blasto-
cyst stage (White et al., 1999) and even fewer progressing far
enough to implant, survive pregnancy and produce live offspring
(Wilmut et al., 1997). One of the major abnormalities associated
with NT offspring is the production of abnormal placentae which
are thought to be the cause of many fetal deaths (Cibelli et al.,
2002). Incorrect reprogramming of imprinted genes has also been
cited as one of the major factors which leads to early fetal death.
This was highlighted by non-surviving NT calves having incorrect
expression of imprinted genes, namely Igf2, Igf2r and H19 in
some tissues, whereas surviving adult clones had normal expres-
sion at these loci except for Igf2 in muscle (Yang et al., 2005).
Furthermore, in mouse NT embryos and offspring irregular pat-
terns of gene expression have been observed most likely as a result
of inappropriate reprogramming (Humpherys et al., 2002).
Although the process of NT for human reproductive purposes is
ethically unacceptable and is banned in many countries (UK –
Human Fertilisation and Embryology Act, 1990; USA – H.R. 534
Office of Legislative Policy and Analysis, 2003; South Korea – see
Normile and Mann, 2005), its use as a means of producing histo-
compatible stem cells for treatment of various diseases is likely to
have a significant impact. Cell replacement therapy has great
potential for the treatment of certain conditions such as myocar-
dial infarction (Rubart and Field, 2006) and Parkinson’s disease
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(Taylor and Minger, 2005) and as a replacement for tissue/organ
transplantation (Cortesini, 2005). To date, encouraging results have
been obtained in animal studies, whereby hESC-derived neural pre-
cursors (Wernig et al., 2004) and cardiomyocytes (Laflamme et al.,
2005) were successfully transplanted into animal organs. However,
considerable characterization and validation of precursor cells
derived from hESCs still needs to be undertaken before cell replace-
ment can be used as an effective therapy in humans. Some success
at generating NT-derived ESCs has so far been achieved in mouse
models (Munsie et al., 2000; Wakayama et al., 2001), and its use as
a means of delivering the patient’s own chromosomal DNA with the
corrected gene for a single gene disorder has been demonstrated in
the mouse (Rideout et al., 2002).
One of the rate-limiting factors in generating autologous ESCs,
i.e. stem cells possessing the patient’s own chromosomal and
mtDNA compositions is the regulation of the mtDNA composi-
tion. In this respect, a considerable amount can be learnt from
those offspring derived from NT through either ECNT or SCNT.
Here, transmission results in either homoplasmy derived from the
recipient oocyte mtDNA or heteroplasmy resulting from transfer
of both donor and recipient mtDNA (reviewed in St. John et al.,
2004a,b). This is probably because of the random pattern of
mtDNA segregation during embryogenesis (reviewed in Shoubridge,
2000). Consequently, it is apparent that no real mechanism is cur-
rently understood that could account for the irregular patterns of
mtDNA transmission observed. One parallel that can be drawn
from both ECNT and SCNT is that the range of donor mtDNA
transmitted is relatively similar at 0–57% (Hiendleder et al., 1999)
and 0–59% (Takeda et al., 2003), respectively. However, two
explanations could exist for those studies not detecting donor
mtDNA in live offspring: (i) no donor mtDNA is actually present
or (ii) too few tissues have been analysed. Consequently, the true
extent of heteroplasmy is difficult to determine. This is perhaps
exemplified by the recent studies of pig (Takeda et al., 2006), cow
(Takeda et al., 2003) and mouse (Inoue et al., 2004) NT-derived
offspring, where varying levels of heteroplasmy has been
observed between the tissues. This would indicate that if all tis-
sues are not analysed, then these studies are not truly subjective.
Furthermore, investigations should include analysis of the surro-
gate mother’s mtDNA as leakage through the placenta into fetal
blood has been reported in cattle (Hiendleder et al., 2004).
The initial number of donor mtDNA molecules introduced into
the recipient oocyte also does not necessarily influence whether
donor mtDNA is actually transmitted. Using blastomeres from
more advanced embryonic stages in bovine NT has resulted in
reduced levels of heteroplasmy being reported (Steinborn et al.,
1998). However, this was not a uniform pattern as two offspring
derived from 52-cell morula blastomeres contained less donor
mtDNA than offspring derived from 92-cell morula blastomeres.
A further issue is the stage of embryonic development of the donor
cell. A recent analysis of two NT-derived monkey offspring
(St. John and Schatten, 2004) demonstrated mtDNA transmission
from both the recipient oocyte and the donor cell. In this instance,
the early IVF blastomere (8- to 12-cell stage) still contained sperm
mtDNA. Consequently, the offspring possessed three different
populations of mtDNA. Furthermore, the depletion of donor cell
mtDNA to residual levels (<0.02% of its original content) still
resulted in the persistence of some mtDNA at the blastocyst stage
in sheep NT (Lloyd et al., 2006).
The use of a somatic donor cell with accompanying mitochon-
dria not only raises interesting questions with regard to the differ-
entiated status of nucleus but also of the mitochondria. During
development, from the inner cell mass to a fully differentiated cell,
mitochondria increase in number to meet the metabolic require-
ments of that specialized cell. The proliferation of mitochondria
further discriminates between the number of mtDNA copies per
mitochondrion and cell type, with higher ATP users possessing
greater copy numbers (Moyes et al., 1998). Therefore, for SCNT,
the mitochondria accompanying the donor cell should also be
reprogrammed to the embryonic state, as is the case for the donor
nucleus. Failure to do this may result in embryos containing mito-
chondria with insufficient plasticity to suit a multitude of cell
types that they will contribute to. The persistence of donor mito-
chondria could also influence the metabolic pathways used during
early development and explain why improved developmental rates
are observed in those embryos cultured in media that enhance
anaerobic respiration (Chung et al., 2002). It is further evident that
the injection of somatic donor mitochondria into oocytes which
are then parthenogenetically activated is detrimental to embryonic
development though this is not observed with donor ooplasm
(Takeda et al., 2005).
Interaction between multiple wild-type mitochondrial 
genomes
It has not been clearly demonstrated whether heteroplasmy result-
ing from two wild-type mtDNA molecules can be detrimental to
the offspring and result in mitochondrial disease. This is partly
because many post-mortem results have not been published, and
the cause of many deaths following NT is not documented. Conse-
quently, we are unsure whether those offspring that survive are the
exception to the rule. However, from one report, some common
causes of death in sheep NT offspring are similar to symptoms of
mitochondrial diseases, including brain, kidney and liver defects
(McCreath et al., 2000) and in a series of other species (Cibelli
et al., 2002). Sequence differences due to mtDNA from a ‘foreign’
source can give rise to proteins with altered amino acid sequences.
This has been demonstrated in both cattle (Steinborn et al., 2002)
and pigs (St. John et al., 2005b) and may result in inadequate
interaction between the individual subunits of the ETC. This
would result in reduced energy production capacity and symptoms
common to mitochondrial disease and influence embryo and fetal
survival. The question is whether handmade cloning, the fusion of
one or more oocyte cytoplasts with a somatic cell (Vajta et al.,
2001), would resolve such issues or complicate them.
The significance of nucleo–mitochondrial interaction
Intergenomic communication is vital for efficient cellular function
as much interaction occurs between nuclear-encoded proteins and
those encoded by the mtDNA genome (reviewed by Scarpulla,
2002). The ETC requires nuclear-encoded proteins to be trans-
ported to the mitochondria and to assemble appropriately
(Stojanovski et al., 2003). Failure of TFAM, TFB1M and TFB2M
to co-ordinate transcription would also have serious implications
for a functional ETC (Falkenberg et al., 2002). Furthermore, fail-
ure of TFAM and PolG to co-ordinate replication would have sim-
ilar outcomes for replication (Larsson et al., 1998; Hance et al.,
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2005). However, NT appears to result in the continued expression
of both these factors during embryo development and could
explain why even residual levels of donor mtDNA persist up to the
blastocyst stage (Lloyd et al., 2006). Failure of TFAM or PolG to
interact with the mtDNA genome, post-implantation, through the
diversity of the donor nucleus and the recipient oocyte’s mtDNA
would result in compromised transcription or replication and
mimic mtDNA-depletion syndromes (Poulton et al., 1994).
Patient-specific ESCs derived by NT would require large num-
bers of good-quality human oocytes which, due to medical, ethi-
cal, legal and moral issues, are a limited resource. Added to this,
the methods of recruitment of donor oocytes for the derivation of
such ESCs have caused considerable outrage recently (Holden,
2005). Cross-species NT offers the opportunity to derive ESCs
that would carry the chromosomal DNA from a patient propagated
in a surrogate ooplasm of another species. Encouragingly, there is
a single report of the generation of a hybrid ESC line following the
transfer of a human nucleus into a rabbit oocyte (Chen et al.,
2003). However, outcomes from cross-species NT further exem-
plify the importance of nucleo-mitochondrial compatibility for
ESC derivation. Use of both human cord fibroblasts with bovine
oocytes (Chang et al., 2003) and chicken blastodermal cells with
rabbit oocytes (Liu et al., 2004) resulted in elimination of the
donor mitochondrial genome by the morula or blastocyst stage of
development. Rhesus macaque donor cells injected into rabbit
oocytes resulted in heteroplasmic embryos but with only the rabbit
mtDNA being replicated after the blastocyst stage (Yang et al.,
2003), suggesting that these too could have soon become homo-
plasmic for the recipient oocyte mtDNA. This suggests either pref-
erential replication of the oocyte mtDNA or degradation of the
mtDNA from the nuclear donor cell.
Analysis of cross-species NT offspring provides further indica-
tions as to potential outcomes for cross-species ESCs. In two com-
binations of cross subspecies cow NT experiments, the donor
nucleus was capable of interaction with both types of mtDNA with
the production of apparently healthy heteroplasmic calves (Steinborn
et al., 2002; Han et al., 2004). However, the combination of Bos
indicus donor cells with Bos taurus oocytes resulted in homo-
plasmic embryos and one offspring (Meirelles et al., 2001). There
has also been one report of preferential replication of mtDNA
from the nuclear donor cell following cross-species NT (Chen
et al., 2002). Here, nuclei from giant panda somatic cells were
injected into rabbit oocytes, and preferential replication of the
panda mtDNA was observed after analysis of the fetuses. This
suggests that some combinations of cross-species NT, particularly
where the species are closely related or a subspecies, may result in
a functional ETC and efficient mitochondrial respiration. How-
ever, more distantly related species might preferentially replicate
their own mtDNA genome because of incompatibility with that in
the recipient oocyte.
Much can also be learnt from somatic cell–cell fusion studies and
xenomitochondrial offspring in relation to outcomes associated
with cross-species NT. For example, one study involved combina-
tions of cells depleted of their mtDNA and exogenous mitochon-
dria from rats and two subspecies of mouse (McKenzie and
Trounce, 2000). Transfer of Mus spretus mtDNA into Mus muscu-
lus cells resulted in heteroplasmy, and no obvious OX-PHOS
defects, probably due to the two types of mice, being closely
related. However, when rat mtDNA was transferred into Mus
musculus cells, its replication and transcription were unaffected,
but OX-PHOS capacity was reduced. Other studies have also dem-
onstrated increased respiratory chain defects following crosses of
greater evolutionary distance both in mice (McKenzie et al., 2003)
and in primates (Kenyon and Moraes, 1997). Effects of species
differences, and also mitochondrial disease, can now be studied in
vivo following the production of xenomitochondrial mice
(McKenzie et al., 2004; Sokolova et al., 2004). Xenomitochon-
drial mice can be produced by (i) direct injection of foreign mito-
chondria into zygotes (Irwin et al., 1999), (ii) pronuclei fusion
with enucleated oocytes (Meirelles and Smith, 1997) followed by
the transfer to surrogate mothers and (iii) the production of ESC
cybrids for injection into blastocysts (Levy et al., 1999). Again, it
has been demonstrated that greater evolutionary distance between
species results in offspring with increased respiratory chain
defects (Trounce et al., 2004). It is most likely that OX-PHOS
defects arose from abnormal combinations of nuclear and mito-
chondrially encoded ETC proteins resulting in abnormal structure
of ETC complexes, a scenario very similar to outcomes that arise
through cross-species NT.
There are many cases where interspecies NT embryos implant
and survive pregnancy but die shortly after birth (Hammer et al.,
2001; Han et al., 2004). These may be a result of inefficient ETC
activity due to species differences. However, should these combi-
nations result in apparently healthy live offspring, it is possible
that phenotypic alterations may still be present. Such outcomes
could affect those mtDNA haplotypes that influence, for example,
milk quality in cattle (Brown et al., 1989), growth and physical
performance in mice (Nagao et al., 1998), a reduction of fertility
in beef cattle (Sutarno et al., 2002) and sperm motility in men
(Ruiz-Pesini et al., 2000). Perhaps, the biggest note of caution is
exemplified by the result of introducing a common carp nucleus
into an enucleated goldfish oocyte, which resulted in the offspring
developing phenotypic features of the goldfish (Sun et al., 2005).
Consequently, the use of cross-species NT for the derivation of
hESCs needs considerable investigation although it offers great
potential.
Are these technologies safe?
Although some experiments have been carried out in animals and
a small number of groups practise invasive ART protocols in
humans, little is known about the likely outcomes of these tech-
niques in relation to the long-term effects on offspring and future
generations. It is essential that we understand the risks of these
techniques before their therapeutic use becomes widespread. The
use of preimplantation genetic diagnosis (PGD) has recently been
proposed for early diagnosis of mitochondrial disease (Dean et al.,
2003). The use of PGD for chromosomal genetic analysis has been
implemented in many clinics. However, its effectiveness needs to
be demonstrated for the detection of potential mtDNA disease
transmission. Some work has indicated its usefulness in this
respect. In the mouse, mtDNA genotypes in polar bodies were
compared with their respective oocytes and in different blast-
omeres within the same early embryo (Dean et al., 2003). The
level of heteroplasmy present in polar bodies and blastomeres was
representative of that in the associated oocytes and embryos, with
the authors therefore concluding that PGD was feasible for the
diagnosis of mitochondrial disease. However, cloned mouse
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offspring (Inoue et al., 2004), various farm animal species such as
pigs (Takeda et al., 2006) and cattle (Hiendleder et al., 2003) and
patients with mitochondrial mutations (Kirches et al., 2001) and
diseases (Ponzetto et al., 1990) often demonstrate varying levels
of heteroplasmy in different tissues. Furthermore, considerable
variation in oocyte-derived mtDNA copy number among intra-
embryo blastomeres has been demonstrated in both the pig (El
Shourbagy et al., 2006) and the human (Lin et al., 2004). There-
fore, even if the proportion of heteroplasmic mtDNA molecules
were the same in each blastomere, the actual number of mutant
molecules is likely to be different. Blastomeres containing lower
numbers of mtDNA molecules will have reduced ATP-generating
capacities compared with their counterparts with higher overall
numbers of mtDNA. Therefore, the effects in tissues resulting
from these blastomeres will be more severe than those resulting
from blastomeres with a larger mtDNA complement. Furthermore,
different tissues require different ATP-generating capacity. Low
levels of wild-type mtDNA in some blastomeres may therefore go
unnoticed if that particular blastomere develops into a low ATP-
requiring tissue. However, this could result in severe mitochon-
drial disease should that blastomere develop into a tissue highly
dependent on OX-PHOS. It is therefore unlikely that PGD would
be a suitable technique to determine the risk of mitochondrial dis-
ease following oocyte reconstruction, especially following GVT,
PNT and NT as all have reported preferential replication of donor
mtDNA. Consequently, an alternative is required.
Conclusion
Mitochondria are vitally important during embryonic development
and tissue differentiation, as demonstrated by the changes in their
localization, activity and morphology in the early embryo. The
propagation of mitochondria before metaphase II and the maternal
transmission of mtDNA ensure that sufficient numbers of the
organelle and its genome are invested into the process of early
embryogenesis. Consequently, these pre-metaphase II events are
under the control of the oocyte nuclear genome, which regulates
transcription and replication, and ensure that transmission is not
affected during a period when there is no nuclear control, i.e.
before activation of the embryonic genome.
In the process of trying to treat various diseases through the
generation of patient-specific stem cells and the use of GVT and
PNT to prevent the transmission of mtDNA-type disease, we
would be taking inappropriate risks if current strategies were
introduced into the clinic. In many ways, our strategies are con-
founding and our ingenuity could turn into our downfall. We are
attempting to provide the nucleus with a new environment in
which it can prosper but, for GVT and PNT, we have forgotten
that this karyoplast is still accompanied by the mutant mtDNA that
we are trying to eradicate. For NT-derived patient-specific stem
cells, GVT and PNT, we are asking the transferred nucleus to
interact with a cytoplasm which may or may not be compatible.
We also expect two or more populations of mtDNA to happily
cohabit. We are however ignoring how the cytoplasm will adjust
to its new nuclear companion in favour of concentrating on the
nucleus and its requirement to achieve pluripotency. Cohabitation
requires considerable foresight, and in this respect we need to
understand considerably more about nucleo-mitochondrial har-
mony before we exploit such technologies. The question still
remaining to be answered is: Can heteroplasmy be tolerated at a
functional level even if it compromises genetic identity? Paradoxi-
cally, inheritance and therefore analysis of recipient oocyte mtDNA
does, however, allow us to confirm whether oocyte reconstruction
has taken place. This is a lesson we have hopefully learnt from the
discredited Korean attempts at generating patient-specific ESCs.
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